HLAG Antikörper (HRP)
-
- Target Alle HLAG Antikörper anzeigen
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HLAG Antikörper ist konjugiert mit HRP
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- Human HLA-G
- Aufreinigung
- Caprylic acid and ammonium sulfate precipitation
- Immunogen
-
Recombinant human HLA class I histocompatibility antigen, alpha chain G protein.
Type of Immunogen: Recombinant protein - Isotyp
- IgG
- Top Product
- Discover our top product HLAG Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.4, 0.03 % Proclin 300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid freeze-thaw cycles.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Target
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- Andere Bezeichnung
- HLA-G (HLAG Produkte)
- Synonyme
- MHC-G antikoerper, B-F antikoerper, B-F-S04 antikoerper, B-F-S05 antikoerper, B-F-S06 antikoerper, B-F-S07 antikoerper, B-FI antikoerper, B-FIV antikoerper, BF2 antikoerper, BFa2 antikoerper, BFw-03 antikoerper, BFw-05 antikoerper, BFz-01 antikoerper, major histocompatibility complex, class I, G antikoerper, MHC BF1 class I antikoerper, HLA-G antikoerper, BF1 antikoerper
- Hintergrund
-
Name/Gene ID: HLA-G
Synonyms: HLA-G, HLAG, HLA-6.0, MHC class I antigen G, HLA G antigen - Gen-ID
- 3135
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-